Mood Tracker+ is a health and fitness app for iOS that provides clinical questionnaires and multi-factor mood logging for users managing mental health conditions.
Product velocity
Unknown
Daily rank 🇺🇸
—
Health & Fitness
Sentiment
4.5
24 reviews
Nemesis
Sober SideKick: Quit Addiction
The App DNA
What makes this app unique?
Users hire this app to track emotional triggers and clinical symptoms, providing data-driven insights for their mental health management.
For Individuals managing mental health conditions like anxiety, depression, or OCD who require clinical-grade tracking tools.
What does it look like?
Key features
Offers medical questionnaires and pre-made care plans for conditions like OCD and PTSD.
Modules for mood, medication, symptoms, and nutrition logging.
Syncs data directly with Apple Health Kit.
How much does it cost?
The app currently operates on a free model with no visible subscription tiers, missing a significant opportunity to monetize high-intent clinical users.
Velocity
Steady developmentShow more...
Who built it?
CARECLINIC SOFTWARE
5 apps tracked · Health & Fitness
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Mood Tracker Journal
How's the Health & Fitness market?
The app occupies a clinical-niche within the Health & Fitness category, relying on medical questionnaire utility rather than the social-network effects seen in top-grossing competitors.
Read the market outlookThe rivals identified
By Chris Thompson
Sober SideKick directly competes for the mental health and habit-tracking user base by leveraging a massive community-driven approach to addiction recovery.
- Features a proprietary empathy algorithm that provides personalized, human-like support during high-stress recovery moments.
- Offers 24/7 access to live support meetings, creating a sticky community network effect target lacks.
- Maintains a massive user base that provides social proof and peer accountability unavailable in our app.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Mood Tracker Journal
Where is it heading?
The mental health market is consolidating around apps that combine clinical data with social accountability or rapid-relief tools. Without a subscription model or community layer, this app remains exposed to competitors that can outspend it on user acquisition, so the PM must prioritize monetization to fund growth.
- The app maintains a steady feature set focused on clinical utility, which prevents churn but fails to capture new casual-user segments.
- The absence of a monetization layer limits the budget for user acquisition, which will likely lead to stagnation against better-funded competitors.
The SWOT
- Clinical-grade questionnaires (PHQ-9, GAD-7) provide professional-level utility
- Apple Health Kit integration centralizes user biometric data
- Develop B2B partnerships with therapists for clinical monitoring
- Introduce premium data-export features for provider-ready reports
Next best moves
Ship premium subscription tier because the current free model misses high-intent monetization → increase ARPU
+ 1 more prioritized moveThe counter-intuitive read
The lack of social features is not a…
Read the full takeFeature gaps
Real-time peer support meetings (available in Sober SideKick but absent here) +2
Since the last report: The app has pivoted its strategic focus toward implementing a subscription model to address monetization gaps while refining its competitive positioning against specialized habit-tracking and medical-adjacent rivals.
Bottom line
The app provides strong clinical utility through validated questionnaires, but it lacks the retention-driving social or gamified layers of its rivals, so the team must pivot to a subscription model to monetize the high-intent clinical demographic.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated